Orange Grove Bio (Series A)

Funding Details
Awarder
Gaingels
Date Award
May 24, 2024
Vertical
Healthcare and Biotech
Funding URL
View Funding Page
Valuation
$126,000,000

Company Info
Founders
Marc Appel
Company Description
A preclinical drug investment and development platform focused on driving down the cost of drug discovery while advancing therapies into clinical trials. Orange Grove Bio (“OGB”) is a preclinical drug investment and development platform.
Market
Healthcare & Wellness
Coinvestors
Lilly Ventures,Cincinnati Children's Hospital Medical Center,Great American Insurance Company,AlleyCorp

Links
Back to Home Back to Healthcare and Biotech Deals View Funding Announcement